Overview

Safety and Efficacy of Pregabalin in Patients With Diabetic Peripheral Neuropathy.

Status:
Completed
Trial end date:
2005-07-01
Target enrollment:
Participant gender:
Summary
To evaluate long-term efficacy and safety of pregabalin in patients with diabetic peripheral neuropathy.
Phase:
Phase 3
Details
Lead Sponsor:
Pfizer
Treatments:
Pregabalin